Latest maintenance data on lithium in bipolar disorder

European Neuropsychopharmacology

Volumn 13, Issue SUPPL. 2, 2003, Pages 51-55

  Goodwin, Guy M ^a   Geddes, John R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bipolar disorder; Depressive relapse; Lamotrigine; Lithium; Maintenance therapy; Manic relapse

Indexed keywords

LAMOTRIGINE; LITHIUM; PLACEBO;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CEREBELLUM INJURY; CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; DEMOGRAPHY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; KIDNEY DISEASE; MEMORY DISORDER; META ANALYSIS; METHODOLOGY; NAUSEA; NEUROTOXICITY; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; THYROID DISEASE; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN;

EID: 0042832902     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00078-6     Document Type: Conference Paper

References (22)

1. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar S.A., Hompland M., Montgomery P., Earl N., Smoot T.M., De Veaugh-Geiss J. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 60:2003;392-400.
2. Burgess, S., Geddes, J., Hawton, K., Townsend, E., Jamison, K., Goodwin, G., 2001. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev CD003013.
3. Calabrese, J.R., 2003. Latest maintenance data on lamotrigine in bipolar disorder. European Neuropsychopharmacology, Supplement 2.
4. Calabrese, J.R., Bowden, C.L., Sachs, G., Yatham, L.N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., DeVeaugh-Geiss, J., 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry, in press.
5. Bowden C.L., Calabrese J.R., McElroy S.L., Gyulai L., Wassef A., Petty F., Pope H.G. Jr., Chou J.C., Keck P.E. Jr., Rhodes L.J., Swann A.C., Hirschfeld R.M., Wozniak P.J. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 57:2000;481-489.
6. Geddes J., Goodwin G. Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials. Br J Psychiatry Suppl. 41:2001;S191-S194.
7. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P., Rosenbaum J.F., Cole K., Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 321:1989;1489-1493.
8. Goodwin F.K. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry. 63:(Suppl 10):2002;5-12.
9. Goodwin G.M. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry. 164:1994;149-152.
10. Hopkins H.S., Gelenberg A.J. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord. 2:2000;174-179.
11. Johnson R.E., McFarland B.H. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry. 153:1996;993-1000.
12. Kleindienst N., Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology. 42:(Suppl 1):2000;2-10.
13. Lang E.J., Davis S.M. Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels. J Clin Neurosci. 9:2002;308-309.
14. Lyskowski J., Nasrallah H.A., Dunner F.J., Bucher K. A longitudinal survey of side effects in a lithium clinic. J Clin Psychiatry. 43:1982;284-286.
15. Mangano W.E., Montine T.J., Hulette C.M. Pathologic assessment of cerebellar atrophy following acute lithium intoxication. Clin Neuropathol. 16:1997;30-33.
16. Moncrieff J. Lithium: evidence reconsidered. Br J Psychiatry. 171:1997;113-119.
17. Oakley P.W., Whyte I.M., Carter G.L. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust NZ J Psychiatry. 35:2001;833-840.
18. Perlis R.H., Sachs G.S., Lafer B., Otto M.W., Faraone S.V., Kane J.M., Rosenbaum J.F. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry. 159:2002;1155-1159.
19. Sproule B. Lithium in bipolar disorder: can drug concentrations predict therapeutic effect? Clin Pharmacokinet. 41:2002;639-660.
20. Suppes T., Baldessarini R.J., Faedda G.L., Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 48:1991;1082-1088.
21. Swann A.C., Bowden C.L., Calabrese J.R., Dilsaver S.C., Morris D.D. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology. 26:2002;530-536.
22. Vestergaard P., Licht R.W., Brodersen A., Rasmussen N.A., Christensen H., Arngrim T., Gronvall B., Kristensen E., Poulstrup I., Wentzer L.R. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels. Acta Psychiatr Scand. 98:1998;310-315.